Viatris (VTRS) Enterprise Value (2019 - 2026)
Viatris (VTRS) posted quarterly Enterprise Value of -$1.8 billion for Q1 2026, down 138.97% year-over-year from $4.6 billion in Q1 2025, and down 36.43% quarter-over-quarter from -$1.3 billion in Q4 2025.
Viatris (VTRS) Enterprise Value (2019 - 2026) Analysis & Trends
Viatris' Enterprise Value history runs 8 years deep, the most recent figure standing at -$1.8 billion for Q1 2026.
- In Q1 2026, Enterprise Value fell 138.97% year-over-year to -$1.8 billion; the TTM figure through Mar 2026 stood at -$1.8 billion (down 138.97% YoY), while the FY2025 annual figure was -$1.3 billion, down 79.65% from the prior year.
- Enterprise Value for Q1 2026 stood at -$1.8 billion, down from -$1.3 billion in the prior quarter.
- The five-year high for Enterprise Value was -$506.6 million in Q1 2023, with the low at -$1.9 billion in Q3 2024.
- The 5-year median for Enterprise Value is -$917.2 million (2024), against an average of -$984.3 million.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value surged 48.09% in 2025, then sank 138.97% in 2026.
- Viatris' Enterprise Value stood at -$1.3 billion in 2022, then grew by 21.43% to -$991.9 million in 2023, then rose by 25.79% to -$736.1 million in 2024, then plunged by 79.65% to -$1.3 billion in 2025, then sank by 36.43% to -$1.8 billion in 2026.
- Business Quant data shows VTRS's Enterprise Value at -$1.8 billion in Q1 2026, -$1.3 billion in Q4 2025, and -$975.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -886.50 Mn |
| Mar 31, 2026 | -1.80 Bn |
| Dec 31, 2025 | -1.32 Bn |
| Sep 30, 2025 | -975.30 Mn |
| Jun 30, 2025 | -566.40 Mn |
| Mar 31, 2025 | -755.00 Mn |
| Dec 31, 2024 | -736.10 Mn |
| Sep 30, 2024 | -1.88 Bn |
| Jun 30, 2024 | -917.20 Mn |
| Mar 31, 2024 | -1.01 Bn |
| Dec 31, 2023 | -991.90 Mn |
| Sep 30, 2023 | -1.31 Bn |
| Jun 30, 2023 | -629.20 Mn |
| Mar 31, 2023 | -506.60 Mn |
| Dec 31, 2022 | -1.26 Bn |
| Sep 30, 2022 | -646.70 Mn |
| Jun 30, 2022 | -664.70 Mn |
| Mar 31, 2022 | -752.40 Mn |
| Dec 31, 2021 | -706.20 Mn |
| Sep 30, 2021 | -756.60 Mn |